Image
Practice Point
Neoadjuvant therapy – Timing
Neoadjuvant systemic therapy should start as soon as diagnosis and staging is completed (ideally within 2-4 weeks).
Neoadjuvant systemic therapy should start as soon as diagnosis and staging is completed (ideally within 2-4 weeks) (Level of evidence – V)
Strong evidence for efficacy with a substantial clinical benefit, strongly recommended
How this guidance was developed
This recommendation was adopted from the ESMO 2019 breast cancer guidelines (Europe). The source recommendation was based on a non-systematic review of the evidence (date not stated). The source recommendation was graded ‘A’ (based on adapted Infectious Diseases Society of America-United States Public Health Service Grading System) by the source guideline authors.
Neoadjuvant therapy – Timing
Practice Point
Neoadjuvant systemic therapy should start as soon as diagnosis and staging is completed (ideally within 2-4 weeks).
Principles in action
Safe and quality care
Image
Multidisciplinary care
Image
Care coordination
This recommendation was adopted from the ESMO 2019 breast cancer guidelines (Europe). The source recommendation was based on a non-systematic review of the evidence (date not stated). The source recommendation was graded ‘A’ (based on adapted Infectious Diseases Society of America-United States Public Health Service Grading System) by the source guideline authors.